eTHE (n = 166) | |
---|---|
Age (years) | 67.0 (13.0) |
Gender (male/female)a | 130/36 (78.3/21.7) |
ASA score 2a | 53 (31.9) |
ASA score 3a | 103 (62.0) |
ASA score 4a | 10 (6.0) |
Pulmonary diseasea | 49 (29.5) |
Cardiovascular diseasea | 87 (52.4) |
Neoadjuvant treatmenta | 144 (86.7) |
cT-stage, n (%) | |
cT1 | 14 (8.4) |
cT2 | 44 (26.5) |
cT3 | 106 (63.9) |
cT4 | 2 (1.2) |
cN-stage, n (%) | |
cNo | 38 (22.9) |
cN1 | 97 (58.4) |
cN2 | 30 (18.1) |
cN3 | 1 (0.6) |